{"pending_diagnosis": "<b>DIAGNOSIS:</b>\nThe patient suffered a late-onset presentation of <span class=\"tg-spoiler\">Ornithine Transcarbamylase (OTC) Deficiency</span>, the most common inherited disorder of the urea cycle.\n\n<b>THE SMOKING GUN:</b>\nThe constellation of extreme, acute hyperammonemia (>400 umol/L) combined with a presentation following a period of profound <u><span class=\"tg-spoiler\">high-protein load and significant catabolic stress (intense training)</span></u>, and the <u>absence of both severe ketoacidosis and hypoglycemia</u>, pointed definitively toward a Urea Cycle Disorder (UCD). Subsequent plasma amino acid chromatography showed profoundly low citrulline and arginine, and urine organic acid analysis revealed high orotic acid\u2014the specific biochemical signature of OTC deficiency.\n\n<b>PATHOPHYSIOLOGY:</b>\nOTC is an essential enzyme in the mitochondria responsible for converting carbamoyl phosphate and ornithine into citrulline. OTC deficiency is X-linked. While severe forms present in neonates, attenuated mutations (late-onset) can remain asymptomatic until triggered by significant metabolic stress (infection, fever, starvation, or, as in this case, <u>a high-protein anabolic load</u>). Failure of the urea cycle leads to the rapid, toxic accumulation of ammonia (NH3) in the bloodstream. Ammonia crosses the blood-brain barrier, converting astrocytes into Alzheimer Type II cells, leading to cerebral swelling, intracranial hypertension, and irreversible neurological damage (encephalopathy). Immediate treatment requires protein restriction, ammonia scavengers (sodium phenylacetate/benzoate), and often emergent hemodialysis or continuous renal replacement therapy (CRRT) to rapidly clear the ammonia."}